AR230991A1 - Un procedimiento para preparar nuevos derivados benzoxazolicos - Google Patents

Un procedimiento para preparar nuevos derivados benzoxazolicos

Info

Publication number
AR230991A1
AR230991A1 AR247979A AR24797973A AR230991A1 AR 230991 A1 AR230991 A1 AR 230991A1 AR 247979 A AR247979 A AR 247979A AR 24797973 A AR24797973 A AR 24797973A AR 230991 A1 AR230991 A1 AR 230991A1
Authority
AR
Argentina
Prior art keywords
benzoxazolic
derivatives
procedure
preparing new
preparing
Prior art date
Application number
AR247979A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of AR230991A1 publication Critical patent/AR230991A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
AR247979A 1972-05-18 1973-05-11 Un procedimiento para preparar nuevos derivados benzoxazolicos AR230991A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2340972A GB1435721A (en) 1972-05-18 1972-05-18 Benzoxazole derivatives

Publications (1)

Publication Number Publication Date
AR230991A1 true AR230991A1 (es) 1984-08-31

Family

ID=10195157

Family Applications (4)

Application Number Title Priority Date Filing Date
AR247979A AR230991A1 (es) 1972-05-18 1973-05-11 Un procedimiento para preparar nuevos derivados benzoxazolicos
AR257862A AR207857A1 (es) 1972-05-18 1975-01-01 Procedimiento para fabricar un acido benzoxazolico
AR257863A AR205021A1 (es) 1972-05-18 1975-01-01 Intermediarios benzoxazolicos utiles en la preparacion de compuestos biologicamente activos
AR257861A AR212010A1 (es) 1972-05-18 1976-03-06 Procedimiento para preparar nuevos compuestos derivados del acido 2-(p-clorofenil)-5-benzoxazolil acetico o propionico,particularmente utiles como agentes activos analgesicos,antipireticos,antiinflamatorios,asi como tamblen inhibidores de la sintesis o liberacion de prostaglandina

Family Applications After (3)

Application Number Title Priority Date Filing Date
AR257862A AR207857A1 (es) 1972-05-18 1975-01-01 Procedimiento para fabricar un acido benzoxazolico
AR257863A AR205021A1 (es) 1972-05-18 1975-01-01 Intermediarios benzoxazolicos utiles en la preparacion de compuestos biologicamente activos
AR257861A AR212010A1 (es) 1972-05-18 1976-03-06 Procedimiento para preparar nuevos compuestos derivados del acido 2-(p-clorofenil)-5-benzoxazolil acetico o propionico,particularmente utiles como agentes activos analgesicos,antipireticos,antiinflamatorios,asi como tamblen inhibidores de la sintesis o liberacion de prostaglandina

Country Status (31)

Country Link
US (1) US3912748A (fr)
JP (6) JPS5912672B2 (fr)
KR (1) KR780000234B1 (fr)
AR (4) AR230991A1 (fr)
AT (1) AT333752B (fr)
BE (1) BE799790A (fr)
BG (1) BG21408A3 (fr)
CA (1) CA1029019A (fr)
CH (5) CH592071A5 (fr)
CS (1) CS200455B2 (fr)
CY (1) CY1016A (fr)
DD (1) DD105229A5 (fr)
DE (1) DE2324443A1 (fr)
DK (1) DK140340B (fr)
ES (1) ES414863A1 (fr)
FR (2) FR2184966B1 (fr)
GB (1) GB1435721A (fr)
HK (1) HK72579A (fr)
HU (1) HU167933B (fr)
IE (2) IE37564B1 (fr)
IL (2) IL42102A (fr)
KE (1) KE2975A (fr)
MY (1) MY8000063A (fr)
NL (1) NL170145C (fr)
PH (3) PH9685A (fr)
PL (3) PL94208B1 (fr)
RO (2) RO66800A (fr)
SE (3) SE386174B (fr)
SU (3) SU574157A3 (fr)
YU (3) YU130473A (fr)
ZA (1) ZA732791B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888864A (en) 1973-06-29 1975-06-10 Hoffmann La Roche Amino lower alkyl ether derivatives of opium alkaloids
GB1495488A (en) * 1976-06-23 1977-12-21 Ippco Int Pharma Patents Co Es Optically active 2-(2-phenyl-5-benzoxazolyl)propionic acids
US4087437A (en) * 1976-09-07 1978-05-02 Eli Lilly And Company 2-Phenyl-5-benzoxazolylalkanoic acid purification process
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen
IT1099589B (it) * 1978-08-04 1985-09-18 Ravizza Spa Processo per la preparazione di derivati dell'acido benzoxazolil propionico
CA1125768A (fr) * 1978-10-31 1982-06-15 Hoffmann-La Roche Limited Derives de benzoxazole
GB2058381B (en) 1979-07-18 1983-01-19 Fuji Photo Film Co Ltd Colour photographic light-sensitive material containing dye-releasing redox compound
GR75153B (fr) * 1981-03-27 1984-07-13 Lilly Co Eli
IT1157295B (it) * 1982-07-19 1987-02-11 Ravizza Spa Processo perfezionato per la preparazione di derivati dell'acido benzoxazolil propionico
DE3413875A1 (de) * 1984-04-12 1985-10-17 Ludwig Heumann & Co GmbH, 8500 Nürnberg Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel
IT1177017B (it) * 1984-10-22 1987-08-26 Ravizza Spa Processo per la preparazione dell'acido 2(4-flurofenil)alfa-metil-5-benzox azoloacetico
US4873259A (en) * 1987-06-10 1989-10-10 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
US4822809A (en) * 1987-11-13 1989-04-18 Abbott Laboratories Benzazole lipoxygenase inhibiting compounds
IT1233836B (it) * 1988-01-13 1992-04-21 Euroresearch Srl Sali idrosolubili dell'acido (+)2-(4 fluorofenil)-alfa-metil-5 benzoxazolo acetato.
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
AU2003283597A1 (en) * 2002-11-16 2004-06-15 Oxford Glycosciences (Uk) Ltd Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
JP4790594B2 (ja) * 2003-02-25 2011-10-12 トポターゲット ユーケー リミテッド Hdacインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物
CA2589495C (fr) * 2004-12-15 2013-10-01 Dompe Pha.R.Ma. S.P.A. Derives de l'acide 2-arylpropionique et compositions pharmaceutiques contenant ceux-ci
EP2336117A1 (fr) 2005-05-26 2011-06-22 Neuron Systems, Inc Composés hétérocycliques pour le traitement des maladies rétiniennes
JP5369854B2 (ja) 2008-04-21 2013-12-18 住友化学株式会社 有害節足動物防除組成物および縮合複素環化合物
CA2782015C (fr) 2009-12-11 2020-08-25 Neuron Systems, Inc. Compositions ophthalmiques topiques et methodes de traitement de la degenerescence maculaire
SG11201505587YA (en) 2013-01-23 2015-08-28 Aldeyra Therapeutics Inc Toxic aldehyde related diseases and treatment
WO2014116593A1 (fr) 2013-01-25 2014-07-31 Aldexa Therapeutics, Inc. Nouveaux pièges dans le traitement de la dégénérescence maculaire
WO2016021706A1 (fr) * 2014-08-08 2016-02-11 カズマパートナーズ株式会社 Composé hétérocyclique condensé
EP4400106A1 (fr) 2015-08-21 2024-07-17 Aldeyra Therapeutics, Inc. Composés deutérés et leurs utilisations
US11129823B2 (en) 2016-05-09 2021-09-28 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
ES2968462T3 (es) 2017-03-16 2024-05-09 Aldeyra Therapeutics Inc Sal polimórfica de 6-cloro-3-amino-2(2-hidroxiprolil) quinolina y usos de la misma
US11040039B2 (en) 2017-10-10 2021-06-22 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
EP3833660A4 (fr) 2018-08-06 2022-05-11 Aldeyra Therapeutics, Inc. Composés polymorphes et leurs utilisations
EP3856478A4 (fr) 2018-09-25 2022-06-08 Aldeyra Therapeutics, Inc. Formulations pour le traitement de la maladie de l'oeil sec
JP2022526917A (ja) 2019-03-26 2022-05-27 アルデイラ セラピューティクス, インコーポレイテッド 眼科用製剤およびその使用
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
JP2022530967A (ja) 2019-05-02 2022-07-05 アルデイラ セラピューティクス, インコーポレイテッド 多形化合物およびその使用
JP2023526016A (ja) 2020-05-13 2023-06-20 アルデイラ セラピューティクス, インコーポレイテッド 医薬製剤およびその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70860A (fr) *
NL285932A (fr) * 1961-11-27
CH516339A (de) * 1969-03-03 1971-12-15 Ciba Geigy Ag Verwendung von Azolverbindungen als Antioxydantien
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
IL37633A (en) * 1970-09-10 1975-08-31 Merck & Co Inc 2-(4-(2-benzoxazolyl)phenyl)alkanoic acid derivatives
DE2115926C3 (de) * 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
GB1491863A (en) * 1973-10-23 1977-11-16 Lilly Industries Ltd 2,5-or 2,6-disubstituted benzoxazoles
GB1590587A (en) * 1977-06-28 1981-06-03 Lilly Industries Ltd Benoxaprofen

Also Published As

Publication number Publication date
SE434399B (sv) 1984-07-23
NL7307018A (fr) 1973-11-20
CH587834A5 (fr) 1977-05-13
SU582762A3 (ru) 1977-11-30
NL170145B (nl) 1982-05-03
JPS6021976B2 (ja) 1985-05-30
DE2324443A1 (de) 1973-11-29
BG21408A3 (bg) 1976-05-20
YU36298B (en) 1982-06-18
IE37564B1 (en) 1977-08-17
IE37563L (en) 1973-11-18
DK140340B (da) 1979-08-06
JPS4954363A (fr) 1974-05-27
CH592071A5 (fr) 1977-10-14
KE2975A (en) 1979-07-20
ES414863A1 (es) 1976-02-01
US3912748A (en) 1975-10-14
CA1029019A (fr) 1978-04-04
JPS56167674A (en) 1981-12-23
YU130473A (en) 1981-08-31
AR205021A1 (es) 1976-03-31
CH595362A5 (fr) 1978-02-15
PL89247B1 (fr) 1976-11-30
CH595361A5 (fr) 1978-02-15
CY1016A (en) 1979-11-23
JPS56167673A (en) 1981-12-23
AT333752B (de) 1976-12-10
RO66800A (fr) 1982-03-24
RO66278A (fr) 1981-06-26
SU580837A3 (ru) 1977-11-15
IE37564L (en) 1973-11-18
AU5590773A (en) 1974-11-21
SE386174B (sv) 1976-08-02
HK72579A (en) 1979-10-19
IL48711A0 (en) 1976-02-29
FR2184966A1 (fr) 1973-12-28
PL94208B1 (fr) 1977-07-30
IE37563B1 (en) 1977-08-17
CS200455B2 (en) 1980-09-15
JPS5912672B2 (ja) 1984-03-24
GB1435721A (en) 1976-05-12
HU167933B (fr) 1976-01-28
AR212010A1 (es) 1978-04-28
PH9685A (en) 1976-02-10
IL42102A0 (en) 1973-06-29
MY8000063A (en) 1980-12-31
JPS56167675A (en) 1981-12-23
JPS56167645A (en) 1981-12-23
IL42102A (en) 1977-07-31
YU117079A (en) 1981-08-31
FR2184966B1 (fr) 1979-01-12
FR2284592B1 (fr) 1979-01-05
SU574157A3 (ru) 1977-09-25
DK140340C (fr) 1979-12-31
AR207857A1 (es) 1976-11-08
SE7509387L (sv) 1975-08-22
JPS59161346A (ja) 1984-09-12
SE435838B (sv) 1984-10-22
BE799790A (fr) 1973-11-19
ATA432573A (de) 1976-04-15
KR780000234B1 (en) 1978-07-01
JPS5929185B2 (ja) 1984-07-18
PH11718A (en) 1978-05-30
NL170145C (nl) 1982-10-01
DD105229A5 (fr) 1974-04-12
PL92565B1 (fr) 1977-04-30
FR2284592A1 (fr) 1976-04-09
SE7710602L (sv) 1977-09-21
ZA732791B (en) 1974-12-24
CH594643A5 (fr) 1978-01-13
PH10704A (en) 1977-08-24
YU117179A (en) 1981-08-31

Similar Documents

Publication Publication Date Title
AR230991A1 (es) Un procedimiento para preparar nuevos derivados benzoxazolicos
AR221816A1 (es) Metodo para preparar nuevos derivados de bencimidazol-2-carbamato-5(6)-sustituidos
AR195350A1 (es) Un procedimiento para preparar tri-p-toluensulfonato de s-adenosil-l-metionina
BR7304494D0 (pt) Maquina aperfeicoada de dupla torcao para formar cordas
AR195314A1 (es) Procedimiento para preparar derivados de piperidinoalcanol alfa-aril-4-sustituidos
AR204984A1 (es) Procedimiento para preparar compuestos de 3-alcoxi-7-acilamido-cefem-4-carboxilico
AR194346A1 (es) Un procedimiento para preparar alcanodiaminas sustituidas
AR200347A1 (es) Procedimiento para preparar derivados de la piperazina
AR194803A1 (es) Un procedimiento para preparar urea
AR197237A1 (es) Un procedimiento para preparar tiometilcefalosporinas 7-p-hidroxilfenilacetamido-3-heterociclicos
AR216885A1 (es) Procedimiento para preparar aminonicotinonitrilos
AR203500A1 (es) Procedimiento para preparar nuevos derivados de n-aminoalquil-2-aminoindano
AR200024A1 (es) Un procedimiento para preparar un compuesto de amidinourea
AR199619A1 (es) Un procedimiento para preparar 17beta-hidroxi-16,16-dimetilestr-4-en 3-ona
AR197500A1 (es) Metodo para preparar un derivado de escopolamina
AR195346A1 (es) Metodo para preparar un polisacarido polihalogenohemiacetalico
AR194026A1 (es) Un procedimiento para la obtencion de derivados de nebularina heterociclicamente sustituidos
AR210320A1 (es) Un procedimiento para preparar 4-oxo-2-imidazolidinilidenoureas
AR203532A1 (es) Un procedimiento para la obtencion de nitroimidazolitriazolopiridazinas
AR194979A1 (es) Un procedimiento para fabricar pasta
AR200729A1 (es) Procedimiento para preparar derivados de difenilmetano
AR200145A1 (es) Un procedimiento para preparar acidos fenilaceticos 3-alcoxi-5-sustituidos
AR203833A1 (es) Procedimiento para preparar compuestos de 16-alfa-ciano-pregn-5-en-20-ona
AR206778A1 (es) Procedimiento mejorado para preparar un derivado de cefalosporina
AR207742A1 (es) Procedimiento para preparar(3-fosfonotioureido)ureidobencenos